Vasgen Organics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
About Vasgen Organics
Vasgen Organics Private Limited (VOPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2009 and has a history of 15 years and eight months. Its registered office is in Delhi, India.
The Corporate was formerly known as Catalent Lifecare Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 M.
Rakshit Gulati and Chanchal Gulati serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2009PTC190660
-
Company No.
190660
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 May 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Vasgen Organics Private Limited offer?
Vasgen Organics Private Limited offers a wide range of products and services, including Anti Asthma Drug, Theophylline Tablet, Antipyretic Medication, Paracetamol Tablets, Aceclofenac Tablet, Aceclofenac Paracetamol Serratiopeptidase Tablet, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Vasgen Organics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakshit Gulati
|
Director | 27-May-2009 | Current |
|
Chanchal Gulati
|
Director | 01-Apr-2016 | Current |
Financial Performance of Vasgen Organics.
Vasgen Organics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vasgen Organics?
In 2017, Vasgen Organics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | State Bank Of India | ₹1.20 M | Open |
How Many Employees Work at Vasgen Organics?
Unlock and access historical data on people associated with Vasgen Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vasgen Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vasgen Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
